Skip to main content
. 2026 Apr 24;18(9):1366. doi: 10.3390/cancers18091366
PSA Prostate-Specific Antigen
cfDNA Cell-free DNA
CTCs Circulating Tumor Cells
EVs Extracellular Vesicles
TEPs Tumor-Educated Platelets
ctDNA Circulating Tumor DNA
CRPC Castration-Resistant Prostate Cancer
mCRPC Metastatic Castration-Resistant Prostate Cancer
HRR Homologous Recombination Repair
PARPi PARP inhibitors
EMA European Medicines Agency
SNV Single Nucleotide Variation
INDEL insertions/deletions
CNV Copy Number Variation
NGS Next-Generation Sequencing
MRD Minimal Residual Disease
AR Androgen Receptor
AUC Area Under the Curve
CH Clonal Hematopoiesis
ESMO European Society for Medical Oncology
mHSPC Metastatic Hormone-Sensitive Prostate Cancer
ARSIs androgen receptor signaling inhibitors
IHC Immunohistochemistry
RT-PCR Real-Time PCR
RISH RNA in situ hybridization
MISEV Minimal Information for Studies of Extracellular Vesicles